Although TRAIL-resistant tumor cells exist, Mueller et al. (2011) proved that, in selected colon cancer cells, TRAIL-MSC could overcome resistance via direct intercellular interaction, thereby inhibiting the growth of HCT-8 and HT29 cells [107]. Here, TNFSF10 is linked to neoplasm.